In phosphatase and tensin homolog deleted from chromosome 10 (PTEN)-deficient breast cancer cells, KU-60019 combined with cisplatin induced synthetic lethality with increasing γH2AX foci and PARP cleavage [45]. Here, PARP1 is linked to breast carcinoma.